Regeneron's Axokine Story Continues; Subset Holds Hope April 7, 2003 By Randy Osborne "It's all Axokine," said analyst Steven Harr with Morgan Stanley in New York, earlier this month.Read More
Manufacturing, Marketing And Distribution Agreements Between Biotech And Pharmaceutical Companies: Dec. 19, 2002 - March 24, 2003# March 31, 2003
Biotech - Big Pharma Collaborations: Modified And Terminated Agreements, Dec. 19, 2002 - March 24, 2003# March 31, 2003
RSS